Cargando…

Combined Modality Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer: How (Should) We Do It? A Narrative Review

Organ-sparing combined-modality treatment for muscle-invasive bladder cancer remains underutilized despite high-quality evidence regarding its efficacy, safety, and preservation of quality of life. It may be offered to patients unwilling to undergo radical cystectomy, as well as those unfit for neoa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lemiński, Artur, Michalski, Wojciech, Masojć, Bartłomiej, Kaczmarek, Krystian, Małkiewicz, Bartosz, Kienitz, Jakub, Zawisza-Lemińska, Barbara, Falco, Michał, Słojewski, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960746/ https://www.ncbi.nlm.nih.gov/pubmed/36836093 http://dx.doi.org/10.3390/jcm12041560

Ejemplares similares

The Influence of Lymph Node Count on Oncological Outcome of Radical Cystectomy in Chemotherapy Pre-Treated and Chemotherapy-Naïve Patients with Muscle Invasive Bladder Cancer
por: Lemiński, Artur, et al.
Publicado: (2021)

Comparison of Laparoscopic and Open Radical Cystectomy for Muscle-Invasive Bladder Cancer
por: Lisiński, Janusz, et al.
Publicado: (2022)

Educational and Psychological Support Combined with Minimally Invasive Surgical Technique Reduces Perioperative Depression and Anxiety in Patients with Bladder Cancer Undergoing Radical Cystectomy
por: Lemiński, Artur, et al.
Publicado: (2021)

Diminishing the Gender-Related Disparity in Survival among Chemotherapy Pre-Treated Patients after Radical Cystectomy—A Multicenter Observational Study
por: Kaczmarek, Krystian, et al.
Publicado: (2023)

Assessment of the infiltrative character of bladder cancer at the time of transurethral resection: a single center study
por: Grzegółkowski, Paweł, et al.
Publicado: (2016)

Adequate Pelvic Lymph Node Dissection in Radical Cystectomy in the Era of Neoadjuvant Chemotherapy: A Meta-Analysis and Systematic Review
por: Kaczmarek, Krystian, et al.
Publicado: (2023)

Increased One-Year Mortality Among Elderly Patients After Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective, Observational Comparative Study
por: Lemiński, Artur, et al.
Publicado: (2022)

Influence of Neoadjuvant Chemotherapy on Survival Outcomes of Radical Cystectomy in Pathologically Proven Positive and Negative Lymph Nodes
por: Kaczmarek, Krystian, et al.
Publicado: (2023)

AUTHOR'S REPLY
por: Grzegółkowski, Paweł, et al.
Publicado: (2017)

Neoadjuvant chemotherapy with dose dense MVAC is associated with improved survival after radical cystectomy compared to other cytotoxic regimens: A tertiary center experience
por: Lemiński, Artur, et al.
Publicado: (2021)

18F-choline positron emission tomography/computed tomography guided laparoscopic salvage lymph node dissection in patients after radical prostatectomy
por: Kubis, Markiian, et al.
Publicado: (2020)

Survival differences of patients with ureteral versus pelvicalyceal tumours: a systematic review and meta-analysis
por: Kaczmarek, Krystian, et al.
Publicado: (2019)

Did the COVID-19 Pandemic Restrict Access to Emergency Urological Services: Assessment of Reorganisation Effectiveness for Hospital Treatment
por: Kaczmarek, Krystian, et al.
Publicado: (2023)

Preoperative pyuria predicts the presence of high-grade bladder carcinoma in patients with bladder tumors
por: Poletajew, Sławomir, et al.
Publicado: (2020)

When Bodybuilding Goes Wrong—Bilateral Renal Artery Thrombosis in a Long-Term Misuser of Anabolic Steroids Treated with AngioJet Rheolytic Thrombectomy
por: Lemiński, Artur, et al.
Publicado: (2022)

Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2021)

Management of Bladder Cancer Patients with Clinical Evidence of Lymph Node Invasion (cN+)
por: Małkiewicz, Bartosz, et al.
Publicado: (2022)

Urinary Microbiome in Bladder Diseases—Review
por: Chorbińska, Joanna, et al.
Publicado: (2023)

The Usefulness of Lymphadenectomy in Bladder Cancer—Current Status
por: Małkiewicz, Bartosz, et al.
Publicado: (2021)

Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
por: El-Taji, Omar M. S., et al.
Publicado: (2016)

Management with Santorini’s Plexus Should Be Personalized during Prostatectomy
por: Wilamowski, Jacek, et al.
Publicado: (2022)

Utility of Lymphadenectomy in Prostate Cancer: Where Do We Stand?
por: Małkiewicz, Bartosz, et al.
Publicado: (2022)

Extended Boari-flap technique as a reconstruction method of total ureteric avulsion
por: Grzegółkowski, Paweł, et al.
Publicado: (2017)

Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer
por: Tholomier, Côme, et al.
Publicado: (2020)

Characteristics and Applications of Canine In Vitro Models of Bladder Cancer in Veterinary Medicine: An Up-to-Date Mini Review
por: Nowak, Łukasz, et al.
Publicado: (2022)

AB007. Bladder-sparing treatments for muscle-invasive bladder cancer
por: Li, Shengwen, et al.
Publicado: (2017)

Bladder neck sparing in radical prostatectomy
por: Smolski, Michal, et al.
Publicado: (2013)

Is the Urinary and Gut Microbiome Associated With Bladder Cancer?
por: Chorbińska, Joanna, et al.
Publicado: (2023)

Bladder-sparing approaches for muscle invasive bladder cancer: a narrative review of current evidence and future perspectives
por: Fan, Xinxiang, et al.
Publicado: (2023)

Selenium and risk of bladder cancer
por: Złowocka-Perłowska, E, et al.
Publicado: (2012)

STAT3 and Its Pathways’ Dysregulation—Underestimated Role in Urological Tumors
por: Golus, Maciej, et al.
Publicado: (2022)

Artificial Intelligence in Urooncology: What We Have and What We Expect
por: Froń, Anita, et al.
Publicado: (2023)

Impact of ureteric stent on outcome of extracorporeal shockwave lithotripsy: A propensity score analysis
por: Kaczmarek, Krystian, et al.
Publicado: (2016)

Clinical outcomes and survival differences between primary, secondary and concomitants carcinoma in situ of urinary bladder treated with BCG immunotherapy
por: Piszczek, Radosław, et al.
Publicado: (2020)

Ubiquitin-Specific Proteases as Potential Therapeutic Targets in Bladder Cancer—In Vitro Evaluation of Degrasyn and PR-619 Activity Using Human and Canine Models
por: Nowak, Łukasz, et al.
Publicado: (2023)

Carcinoma in the inactive bladder – the dilemma of the forgotten organ
por: Kupś, Michał, et al.
Publicado: (2012)

Assessment of the Impact of Pentafecta Parameters Affecting the Quality of Life of Patients Undergoing Laparoscopic Radical Prostatectomy
por: Wojtarowicz, Mateusz, et al.
Publicado: (2023)

Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer
por: Witjes, J Alfred, et al.
Publicado: (2021)

Diagnostic Value of the Sentinel Lymph Node Technique in Patients with Muscle-Invasive Bladder Cancer
por: Małkiewicz, Bartosz, et al.
Publicado: (2023)

Diagnostic Value of Radio-Guided Sentinel Node Detection in Patients with Prostate Cancer Undergoing Radical Prostatectomy with Modified-Extended Lymphadenectomy
por: Małkiewicz, Bartosz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c3sbn1bhqkd1kl264j4mheua8e